Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Iran J Kidney Dis. 2011 Mar;5(2):130-2.

Single dose of rasburicase for treatment of hyperuricemia in acute kidney injury: a report of 3 cases.

Author information

  • 1Department of Pediatric Nephrology, Tehran University of Medical Sciences, Tehran, Iran. nakih@hotmail.com

Abstract

Severe hyperuricemia accompanied by the other comorbidities such as anuria, fluid overload, calcium-phosphate imbalance, and/or tumor lysis syndrome is one of the indications for dialysis in the setting of acute kidney injury. Rasburicase is used in different clinical conditions such as tumor lysis syndrome and uric acid nephropathy. Among referred patients to our center from 2008 to 2010, there were 3 patients who had an indication for dialysis because of hyperuricemia. Contributing factors to the acute kidney injury were multi-organ dysfunction, rapidly progressive glomerulonephritis, and spontaneous tumor lysis syndrome. None of the patients showed any response to treatment with bicarbonate and hydration. After rasburicase administration, serum uric acid level declined, and urine output increased. Treatment with a single low dose of rasburicase would be effective to decrease the serum uric acid level and reverse kidney injury secondary to uric acid nephropathy.

PMID:
21368393
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Iranian Society of Nephrology
    Loading ...
    Write to the Help Desk